Webinar Date: 14/05/2025

Navigating Payload Innovation and Toxicity Trends in ADC Development

Navigating Payload Innovation and Toxicity Trends in ADC Development   Navigating Payload Innovation and Toxicity Trends in ADC Development
 
May 14th 2025, 8am PDT | 11am EDT | 4pm BST

Join us for an exclusive expert-led webinar featuring Yu-Shin Hsu from Beacon ADC and Callum Angus from Hanson Wade Intelligence as they dissect the rapidly evolving world of antibody-drug conjugate payloads. This dynamic session dives deep into the mechanisms, trends, and safety challenges shaping next-generation therapeutics. From tubulin and topoisomerase inhibitors to promising new alternatives, discover what’s driving innovation—and what it means for the future of ADC development.

Key Insights:

  • Payload Mechanisms Decoded: Explore the science behind key payload classes including tubulin and topoisomerase inhibitors, alongside emerging novel options.
  • Data-Driven Trends: Analyze 10+ years of clinical and preclinical development trends to uncover where the field is headed.
  • Safety Under the Microscope: Get a focused review of TOPO1 payload toxicity, including top-line safety data and first-in-human adverse event profiles.
  • Expert Perspectives: Gain strategic insights from two industry leaders with a pulse on current ADC innovation and challenges.

Why Attend?

  • Stay Ahead of the Curve: Understand the evolving landscape of ADC payloads and what’s next in therapeutic innovation.
  • Enhance Strategic Decision-Making: Use real-world data and expert analysis to guide your R&D and clinical strategies.
  • Prioritize Patient Safety: Learn how emerging safety considerations are shaping the development of future ADCs.
  • Engage with Industry Experts: Hear directly from Yu-Shin Hsu and Callum Angus as they share exclusive insights and trend analyses you won’t find anywhere else.

Webinar Leaders

Yu-Shin Hsu

 

House Speaker

Researcher

Beacon

Callum Angus

 

House Speaker

Senior Market Analyst

Hanson Wade Intelligence

Eleni Taoula

 

Moderator

Senior Account Manager

Beacon

You May Also Be Interested In…

Learn More About ADC

What is Beacon ADC?
  • The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
  • Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon ADC

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search